These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1742445)

  • 1. A model for incorporating historical controls into a meta-analysis.
    Begg CB; Pilote L
    Biometrics; 1991 Sep; 47(3):899-906. PubMed ID: 1742445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Random-effects model for meta-analysis of clinical trials: an update.
    DerSimonian R; Kacker R
    Contemp Clin Trials; 2007 Feb; 28(2):105-14. PubMed ID: 16807131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of summary survival curve data.
    Arends LR; Hunink MG; Stijnen T
    Stat Med; 2008 Sep; 27(22):4381-96. PubMed ID: 18465839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Statistical analysis of community-based studies -- presentation and comparison of possible solutions with reference to statistical meta-analytic methods].
    Twardella D; Bruckner T; Blettner M
    Gesundheitswesen; 2005 Jan; 67(1):48-55. PubMed ID: 15672306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of three different models for estimating relative risk in meta-analysis of clinical trials under unobserved heterogeneity.
    Kuhnert R; Böhning D
    Stat Med; 2007 May; 26(11):2277-96. PubMed ID: 16991109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined test procedures in the meta-analysis of controlled clinical trials.
    Knapp G; Hartung J
    Stud Health Technol Inform; 2000; 77():34-8. PubMed ID: 11187570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over.
    Curtin F; Elbourne D; Altman DG
    Stat Med; 2002 Aug; 21(15):2161-73. PubMed ID: 12210631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of statistical methods for meta-analysis.
    Brockwell SE; Gordon IR
    Stat Med; 2001 Mar; 20(6):825-40. PubMed ID: 11252006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implications of publication bias for meta-analysis' other parameter.
    Jackson D
    Stat Med; 2006 Sep; 25(17):2911-21. PubMed ID: 16345059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing for nonparametric Bayesian survival analysis using historical controls.
    Van Ryzin J
    Cancer Treat Rep; 1980; 64(2-3):503-6. PubMed ID: 7407791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semi-parametric modelling of the distribution of the baseline risk in meta-analysis.
    Ghidey W; Lesaffre E; Stijnen T
    Stat Med; 2007 Dec; 26(30):5434-44. PubMed ID: 17893888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical evaluation showed that the Copas selection model provided a useful summary in 80% of meta-analyses.
    Carpenter JR; Schwarzer G; Rücker G; Künstler R
    J Clin Epidemiol; 2009 Jun; 62(6):624-631.e4. PubMed ID: 19282148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial likelihood analysis of within-unit variances in repeated measurement experiments.
    Chinchilli VM; Esinhart JD; Miller WG
    Biometrics; 1995 Mar; 51(1):205-16. PubMed ID: 7766775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meta-analysis of therapeutic and preventive clinical trials].
    Lugosi L; Molnár I
    Orv Hetil; 2000 Dec; 141(51):2779-84. PubMed ID: 11196238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothesis tests for population heterogeneity in meta-analysis.
    Viechtbauer W
    Br J Math Stat Psychol; 2007 May; 60(Pt 1):29-60. PubMed ID: 17535578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of continuous outcome data from individual patients.
    Higgins JP; Whitehead A; Turner RM; Omar RZ; Thompson SG
    Stat Med; 2001 Aug; 20(15):2219-41. PubMed ID: 11468761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arcsine test for publication bias in meta-analyses with binary outcomes.
    Rücker G; Schwarzer G; Carpenter J
    Stat Med; 2008 Feb; 27(5):746-63. PubMed ID: 17592831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of prognostic factors in analysis of historical control studies.
    Gehan EA; Smith TL; Buzdar AU
    Cancer Treat Rep; 1980; 64(2-3):373-9. PubMed ID: 7407774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Borrowing strength from external trials in a meta-analysis.
    Higgins JP; Whitehead A
    Stat Med; 1996 Dec; 15(24):2733-49. PubMed ID: 8981683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach.
    Rondeau V; Michiels S; Liquet B; Pignon JP
    Stat Med; 2008 May; 27(11):1894-910. PubMed ID: 18069745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.